Cristina Rohena

Title: Cristina Rohena: Innovator in Antitumor Compounds

Introduction

Cristina Rohena is a notable inventor based in San Antonio, TX (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activities. Her work focuses on innovative solutions for cancer treatment, showcasing her dedication to advancing medical science.

Latest Patents

Cristina Rohena holds a patent for her invention titled "Polysubstituted pyrroles having microtubule-disrupting, cytotoxic and antitumor activities and methods of use thereof." This patent describes polysubstituted pyrrole compounds, along with their pharmaceutically effective salts, prodrugs, solvates, and hydrates. These compounds exhibit antimitotic, antiproliferative, and cytotoxic activity, particularly against cancer cells that express the drug efflux protein, P-glycoprotein, or the β-III isotype of tubulin. The invention also outlines methods for utilizing these compounds to inhibit the proliferation of cancer cells, including those that are drug-resistant.

Career Highlights

Throughout her career, Cristina has worked with prestigious institutions, including the University of Texas System and Virginia Commonwealth University. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Cristina has collaborated with notable colleagues such as Glen E Kellogg and Chenxiao Da. These partnerships have further enriched her research and development efforts, leading to advancements in cancer treatment methodologies.

Conclusion

Cristina Rohena's innovative work in developing antitumor compounds highlights her commitment to improving cancer therapies. Her contributions to the field are invaluable, and her patent reflects her dedication to finding effective solutions for challenging medical issues.